Document is current
Any future updates will be listed below
-
Authors
Wilson, Alicia S.
Randall, Katrina L.
Pettitt, Jessica A.
Ellyard, Julia I. https://orcid.org/0000-0001-6301-2533
Blumenthal, Antje https://orcid.org/0000-0003-3673-7015
Enders, Anselm https://orcid.org/0000-0001-5933-6463
Quah, Benjamin J.
Bopp, Tobias https://orcid.org/0000-0002-3232-8065
Parish, Christopher R. https://orcid.org/0000-0001-7740-0430
Brüstle, Anne https://orcid.org/0000-0002-3842-5683
-
Funding
Funding for this research was provided by:
Australian Government Research Training Program (RTP) Scholarship
ACT Health Private Practice Trust Fund Grant
Department of Health | National Health and Medical Research Council (APP1052616)
Sirtex Medical Ltd
MS Research Australia project grant (16-122) “Our Health in Our Hands” a strategic initiative of the Australian National University
- License Information
-
More Information
Article History
Received: 3 February 2021
Accepted: 8 January 2022
First Online: 26 January 2022
Competing interests
: Sirtex Medical Ltd has been involved in the commercialization of the histone inhibitor, mCBS, developed by CRP and covered by several patents on which CRP is an inventor. The authors declare no further competing interests.
